O uso da associação de nifedipina e atenolol em formulação galênica única na hipertensão arterial essencial leve a moderada
Year: 1996
Type: article
Study design: Clinical Trial
Abstract: Summary Nifedipine slow release (20 mg) associated toAtenolol (50 mg) in the same galenic preparation(capsule) was given once day for 46 mild-to-moderateessential hypertensive patients during 6 months. Ifnecessary dosage was tritated up to Nifedipine 40 mg+ Atenolol 100 mg (2 capsules). The antihypertensiveefficacy of the association in this study was of 75.6%with blood pressure normalization in 51.4% ofpatients. A small, but significant decrease, in heart ratewas observed. ABPM showed an antihypertensiveeffect of the association for the 24 hours, although itwas greater during the day. Treatment with thisassociation was accompanied by significant reductionin the left ventricular mass index, the posterior walland the septum thickness and an improvement indiastolic function (E/A ratio). No effects of thisassociation were observed upon lipid and glucosemetabolism. The association was well tolerated andthe major side effect observed was ankle oedema. Weconcluded that an association of Nifedipine andAtenolol in a single galenic formulation is an adequateoption for treatment in mild-to-moderate essentialhypertensive patients.
Source: Brazilian Journal of Nephrology
Language: Portuguese
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W179344750
